✦ LIBER ✦

Results of an rtog phase iii trial (rtog 85-27) comparing radiotherapy plus etanidazole (sr-2508) with radiotherapy alone for locally advanced head and neck carcinomas

✍ Scribed by D.J. Lee; T. Pajak; V.A. Marcial; K. Fu; M. Rotman; J.S. Cooper; H.G. Ortiz; J.J. Beitler; R.A. Abrams; W.J. Curran; C.N. Coleman; T.H Wasserman

Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 153 KB
Volume: 30
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(94)90726-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of an RTOG phase III trial (RTOG

Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas

✍ Ding-Jen Lee; Dennis Cosmatos; Victor A. Marcial; Karen K. Fu; Marvin Rotman; Ja 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 1012 KB

Quality-adjusted survival analysis of Ra

Quality-adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) 90-03: Phase III randomized study comparing altered fractionation to standard fractionation radiotherapy for locally advanced head and neck squamous cell carcinoma

✍ Andre A. Konski; Kathryn Winter; Bernard F. Cole; Kie-Kian Ang; Karen K. Fu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

## Abstract ## Background. To evaluate quality‐adjusted survival (QAS) of patients with locally advanced squamous cell carcinoma of the head and neck treated with 4 different radiation fractionation schedules. ## Methods. QAS was calculated using the quality‐adjusted time without toxicity or rel